Search Results - ben+stanger

1 Results Sort By:
Targeting CA19-9 with High-Specificity CAR-T Cells for Pancreatic Cancer
Chimeric antigen receptor (CAR) T cell therapy targeting CA19-9, an antigen over-expressed in several cancers, including 80-90% of pancreatic cancers. Problem: Pancreatic cancer is one of the deadliest common cancers and is now the sixth leading cause of cancer deaths worldwide, underscoring the need for better treatment options. One promising option...
Published: 7/8/2026   |   Updated: 7/8/2026   |   Inventor(s): Ben Stanger, Feiyan Mo
Keywords(s): Cell Therapy, Immunoncology, Immunotherapy, Oncology
Category(s): Technology Classifications > Therapeutics